BioSpace News Archive

Joerns Healthcare has announced that Taylor Smith has been appointed Chief Executive Officer.

a group of more than 85 leading public health organizations announced the launch of a new national campaign called “Keep Up The Rates” to raise awareness about the importance of getting routine vaccinations during the COVID-19 pandemic.

Photocure ASA reported Hexvix®/Cysview® revenues of 53.5 million in the second quarter of 2020, corresponding to growth of three per cent, despite a significant Covid-19 impact in the beginning of the quarter in the U.S.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for unmet medical need indications, announces its results for the second quarter and first half of 2020.

Evotec SE and Novo Nordisk announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office has granted a patent on use and methods of treatment of Crohn’s disease with Foralumab, its proprietary fully human monoclonal antibody, and all other anti-CD3 monoclonal antibodies.

New Leadership Looks to Meet Evolving Needs and Challenges of Global Market, Starting with Establishment of Misato Cold Chain Center

Ultimovacs ASA, a pharmaceutical company developing novel immunotherapies against cancer, announced that patient enrollment has been completed in the ongoing US-based Phase I clinical trial testing Ultimovacs’ lead candidate, UV1, in combination with pembrolizumab as first line treatment in patients with metastatic malignant melanoma.

CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.

Immunovia AB, announced that the company will be hosting the second webinar in the series on Immunovia’s IMMray™ PanCan-d.